financetom
Business
financetom
/
Business
/
ICICI Securities downgrades TCS; says risk-reward ratio not favourable, inflationary spends to return
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ICICI Securities downgrades TCS; says risk-reward ratio not favourable, inflationary spends to return
Jul 9, 2021 5:01 AM

Tata Consultancy Services (TCS) first-quarter missed street expectations. Dollar revenue, profit and margins came in below estimates but the deal pipeline remains strong with an orderbook of over USD 8 billion. Taking note, ICICI Securities has downgraded the stock.

Discussing the earnings fine print and rationale for the downgrade, Sudheer Guntupalli, lead analyst-technology sector said, “My belief is that industry and TCS are seeing a reversion or convergence towards pre-COVID long-term average growth rates."

The company has warned about the softness in the European market for the next one-two quarters.

"Importantly, they have also indicated that by the end of this year most inflationary spends may come back to normal including travel spends as well,” Guntupalli said.

TCS CEO Gopinathan said Europe showed lower growth but maintained that was consolidation on the back of strong growth for four consecutive quarters.

Historically, the long-term 10-15 year average valuations for TCS is in the range of 19-20, "Now it is trading almost 30 times on FY23 basis. Incrementally, given higher scope for disappointment over positive surprises, I believe the risk-reward ratio is not very favourable at this juncture and that is the reason driving our downgrade,” said Guntupalli.

The company is the first major player to have reported its numbers for the June quarter, and its peers in the software industry and other sectors will be following up later.

Meanwhile, domestic brokerage Reliance Securities has said the revenue underperformance was a one-off and welcomed the significant deal wins. It added that TCS is set to be a key beneficiary of an uptick in technology spends over the medium term.

For more, the watch video

(Edited by : Abhishek Jha)

First Published:Jul 9, 2021 2:01 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Kingsway Pharmaceuticals Acquires Strategic Equity Stake in CIGA Healthcare to Expand Access to At-Home and Retail Diagnostic Testing
Nov 17, 2025
BRISTOL, Tenn., Nov. 17, 2025 /PRNewswire/ -- Kingsway Pharmaceuticals, a U.S.-based consumer healthcare company specializing in nationally distributed OTC brands and private label solutions, announced today that it has acquired a strategic minority stake in CIGA Healthcare, a global diagnostics innovator supplying rapid tests and home diagnostic technologies to more than 70 countries. The investment forms a joint venture alignment...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Merlin Labs, Inc. and Inflection Point Acquisition Corp. IV Announce Upsizing of PIPE Investment to More Than $200 Million
Nov 17, 2025
Inflection Point and investors increase PIPE commitments to more than $200 million, including over $85 million of pre-funded PIPE capital BOSTON--(BUSINESS WIRE)-- Merlin Labs, Inc. (“Merlin”), a leading developer of assured, autonomous flight technology for defense customers, and Inflection Point Acquisition Corp. IV ( BACQ ) (“Inflection Point”) today announced a significant increase to their previously disclosed private investment...
Form 8.3
Form 8.3
Nov 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved